A.I. Virtanen -instituutti
A.I. Virtanen Institute for Molecular Sciences

Julkaisut 1995
Publications 1995

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ala-Korpela M et al. Structural changes of lipoprotein lipids by 1H NMR.
2 Ala-Korpela M et al. Quantification of metabolites from single-voxel in vivo 1H NMR data of normal human brain by means of time-domain data analysis.
3 Alhonen L et al. Life-long over-expression of ornithine decarboxylase (ODC) gene in transgenic mice does not lead to generally enhanced tumorigenesis or neuronal degeneration.
4 Castrén E et al. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus.
5 Castrén M et al. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone.
6 Castrén M et al. Transcriptional induction of rat mineralocorticoid receptor gene in neurones by corticosteroids.
7 Halonen T et al. Alfa2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
8 Halonen T et al. Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.
9 Heinonen O et al. Alzheimer pathology of patients carrying apolipoprotein E epsilon4 allele.
10 Heinonen O et al. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.
11 Heinonen O et al. Beta-amyloid-protein immunoreactivity in skin is not a reliable marker of Alzheimer's disease: an autopsy controlled study.
12 Helkala E-L et al. The association of apolipoprotein E polymorphism with memory: a population based study.
13 Helkala E-L et al. Frontal dysfunction and memory deficit in depression and Parkinson's disease.
14 Hiltunen T et al. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions.
15 Hänninen T et al. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia.
16 Jäkälä P et al. Modulation of rat neocortical high-voltage spindle activity by 5-HT 1 /5-HT 2 receptor subtype specific drugs.
17 Jänne J. Siirtogeeniset eläimet.
18 Jänne J. Siirtogeeniset eläimet.
19 Kauppinen L. Human Spermidine Synthase. Purification, Molecular Cloning and Expression.
20 Kauppinen L. Regulation of the human spermidine synthase mRNA translation by its 5'-untranslated region.
21 Kauppinen RA, Alhonen LI. Transgenic animals as models in the study of the neurobiological role of polyamines.
22 Koistinaho J, Sagar SM. NADPH-diaphorase-reactive neurones in the retina.
23 Koivisto K et al. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland.
24 Korhonen J et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo.
25 Korhonen V-P et al. Molecular cloning of a cDNA encoding human spermine synthase.
26 Kosunen O et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
27 Kuikka JT et al. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder.
28 Kälviäinen R et al. Vigabatrin. Clinical use.
29 Kälviäinen R, Riekkinen PJ Sr. New anti-epileptic drugs.
30 Kälviäinen R et al. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy.
31 Laakso M et al. The interuncal distance in Alzheimer disease and age-associated memory impairment.
32 Laakso MP et al. MRI of amygdala fails to diagnose early Alzheimer's disease.
33 Laakso MP et al. Volumes of hippocampus and amygdala in the magnetic resonance imaging based diagnosis of early Alzheimer's disease.
34 Laakso MP et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions.
35 Lehtovirta M et al. Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland.
36 Lehtovirta M et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes.
37 Lukkarinen J et al. Cerebral energy metabolism and immediate early gene induction following severe incomplete ischaemia in transgenic mice overexpressing the human ornithine decarboxylase gene: evidence that putrescine is not neurotoxic in vivo.
38 Miettinen R et al. Short communication: NADPH diaphorase-containing nonpyramidal cells in the rat hippocampus exhibit differential sensitivity to kainic acid.
39 Myöhänen S. Applications of Automated DNA Analysis. A Study of Genes of the Polyamine Biosynthetic Pathway.
40 Niemelä O et al. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease.
41 Peura TT et al. Effects of membrane piercing and the type of pronuclear injection fluid on development of in vitro-produced bovine embryos.
42 Pirttilä T-RM et al. Glucose metabolism in the developing cerebral cortex as detected by 1H {13C} nuclear magnetic resonance spectroscopy ex vivo.
43 Pitkänen A et al. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus.
44 Pitkänen A et al. Subiculum, presubiculum and parasubiculum have different sensitivities to seizure-induced neuronal damage in the rat.
45 Pitkänen M et al. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats.
46 Pitkänen M et al. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks.
47 Pitkänen M et al. Effects of NMDA receptor modulation on hippocampal type 2 theta activity in rats.
48 Reeben M et al. Sequencing of the rat light neurofilament promoter reveals differences in methylation between expressing and non-expressing cell lines, but not tissues.
49 Riekkinen M et al. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.
50 Riekkinen P. Muistilääkkeen tutkiminen alkoi keksimisen ilosta.
51 Riekkinen P Jr et al. Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging.
52 Riekkinen P Jr et al. Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
53 Rimon R et al. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
54 Savander V et al. Intrinsic connections of the rat amygdaloid complex: projections originating in the basal nucleus.
55 Sik A et al. Hippocampal CA1 interneurons: an in vivo intracellular labeling study.
56 Sirviö J. Pitkäkestoinen vahvistuminen (LTP) muistin koodina.
57 Sivenius J et al. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
58 Soininen H et al. Regional cerebral blood flow measured by 99mTC-HMPAO SPECT differs in subgroups of Alzheimer's disease.
59 Soininen H et al. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein e4 allele.
60 Soininen H et al. Increased acetylcholinesterase activity in the CSF of Alzheimer patients carrying apolipoprotein epsilon4 allele.
61 Soininen H et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele.
62 Soininen HS et al. Habituation of auditory N100 correlates with amygdaloid volumes and frontal functions in age-associated memory impairment.
63 Sorvari H et al. Distribution of parvalbumin-immunoreactive cells and fibers in the human amygdaloid complex.
64 Tsukamoto H et al. Experimental liver cirrhosis induced by alcohol and iron.
65 Turner DA et al. Morphometric and electrical properties of reconstructed hippocampal CA3 neurons recorded in vivo.
66 Tuunainen A et al. Short-term withdrawal of antiepileptic medication: effects on attention and memory.
67 Tuunainen A et al. Preoperative EEG predicts memory and selective cognitive functions after temporal lobe surgery.
68 Tuunainen A et al. Spectral EEG during short-term discontinuation of antiepileptic medication in partial epilepsy.
69 Tuunainen A et al. Lateralization of event-related potentials during discontinuation of antiepileptic medication.
70 Usenius T et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo.
71 Valtonen P et al. Effect of alfa2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo.
72 Wahlfors J et al. Development of a rapid PCR method for identification of Helicobacter pylori in dental plaque and gastric biopsy specimens.
73 Wahlfors J et al. Simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis by a rapid PCR method.
74 Wahlfors J et al. Long-term reduction of amplified ornithine decarboxylase sequences in human myeloma cells.
75 Ylinen A. Hippokampus ja muisti.
76 Ylinen A et al. Sharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms.
77 Ylinen A et al. Long-term efficacy and cognitive effects of vigabatrin.
78 Ylinen A et al. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task.
79 Ylinen A et al. Intracellular correlates of hippocampal theta rhythm in identified pyramidal cells, granule cells, and basket cells.
80 Ylä-Herttuala S et al. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.
81 Äikiä M et al. Verbal learning and memory in newly diagnosed partial epilepsy.

A.I. Virtanen -instituutti A.I. Virtanen Institute for Molecular Sciences
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008